Background illustration for clinical trials search

Paid Clinical Trials South Dakota

Discover 282 paid clinical trials in South Dakota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for
Locally Advanced Cervical Adenocarcinoma,
Location: Bath ME, Portland ME, Scarborough ME, Sanford ME,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase3, Recruiting

A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

for
Extensive Stage Small Cell Lung Cancer
Location: Boston MA, New York NY, Philadelphia PA, Pittsburgh PA,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07037758

Phase1, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

Midwest Birth Outcomes and Indigenous American Pregnancy

for
Pregnancy
Location: Fargo ND, Sioux Falls SD
Sponsor: Sanford Health

Sex: Female

Age: 18+

Code: NCT06008561

Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Long Island City NY, Danbury CT, Great Neck NY,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

for
Extensive Stage Lung Small Cell Carcinoma,
Location: Peabody MA, Boston MA, Burlington MA, Waterford CT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06769126

Phase2, Recruiting

Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

for
Dry Eye Disease (DED)
Location: Sioux Falls SD
Sponsor: Vance Thompson Vision

Sex: All

Age: 22+

Code: NCT07155057

Recruiting

Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial

for
Other
Location: Augusta ME, Brunswick ME, Portland ME, Scarborough ME,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06904391

Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Boston MA, Valhalla NY, New York NY, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07630974

Phase1, Phase2, Recruiting

xDot Access Management System Early Feasibility Study

for
Vascular Closure Devices
Location: Milwaukee WI, Downers Grove IL, Saint Cloud MN,
Sponsor: xDot Medical, Inc

Sex: All

Age: 18+

Code: NCT07464353

Recruiting

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

for
Asthma
Location: Hawthorne NY, The Bronx NY, Ocean City NJ, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 12 - 17

Code: NCT06307665

Phase3, Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Portland ME, South Portland ME, Boston MA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase3, Recruiting

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

for
Endometrial Cancer
Location: St. John's, New Haven CT, Mineola NY, New York NY,
Sponsor: BioNTech SE

Sex: Female

Age: 18+

Code: NCT06340568

Phase3, Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: New Haven CT, Quebec, The Bronx NY, Morristown NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase3, Recruiting

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

for
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma,
Location: Bath ME, Portland ME, Scarborough ME, South Portland ME,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06958328

Phase3, Recruiting

NORM-HF Pivotal Study

for
Heart Failure, NYHA Class III Heart Failure,
Location: Philadelphia PA, Jacksonville FL, Tampa FL,
Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)

Sex: All

Age: 18+

Code: NCT07574593

Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for
High Risk Cardiovascular Disease, Hypertension,
Location: Sydney, Moncton, Portsmouth NH, Riverhead NY, Levis,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07181109

Phase3, Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Westerly RI, Worcester MA, Waterford CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061964

Phase2, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

for
Macular Edema Secondary to Inflammation
Location: Boston MA, Waterford CT, Manchester CT, Greenwich CT,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06990399

Phase3, Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

for
Lupus Nephritis
Location: West Long Branch NJ, Willow Grove PA, Rockville MD,
Sponsor: Aurinia Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07611214

Recruiting

Popular cities in South Dakota

AberdeenSioux FallsRapid City